Immunoassays

DGP-A is a solid phase enzyme immunoassay employing synthetic, deamidated gliadinderived peptides for the quantitative detection of IgA antibodies against deamidated Gliadinspecific peptides (DGP) in human serum.

DGP-G is a solid phase enzyme immunoassay employing synthetic, deamidated gliadinderived peptides for the quantitative detection of IgG antibodies against deamidated Gliadinspecific peptides (DGP) in human serum.

SLA/LP is a solid phase enzyme immunoassay employing human recombinant SLA/LP for the quantitative detection of IgG antibodies against soluble liver antigen (SLA) in human serum. The assay is a tool for the diagnosis of autoimmune hepatitis (AIH).

AMA-M2-G is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgG antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).

Borrelia-G is a solid phase enzyme immunoassay for the quantitative detection of IgG antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Borrelia-M is a solid phase enzyme immunoassay for the quantitative detection of IgM antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Protein C is a solid phase enzyme immunoassay for the quantitative determination of Protein C in citrated human plasma. The determination of Protein C aids in the risk estimation of thrombosis.